PURGASOL (DLC Laboratories, Inc.)
Welcome to the PulseAid listing for the PURGASOL drug offered from DLC Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | DLC Laboratories, Inc. |
NON-PROPRIETARY NAME: | Sennosides Docusate Sodium |
SUBSTANCE NAME: | SENNOSIDES; DOCUSATE SODIUM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2009-11-16 |
END MARKETING DATE: | 0000-00-00 |
PURGASOL HUMAN OTC DRUG Details:
Item Description | PURGASOL from DLC Laboratories, Inc. |
LABELER NAME: | DLC Laboratories, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8.6; 50(mg/1; mg/1) |
START MARKETING DATE: | 2009-11-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 24286-1552_83f516d6-7aa5-482f-a597-77d527f89bea |
PRODUCT NDC: | 24286-1552 |
APPLICATION NUMBER: | part334 |
Other SENNOSIDES; DOCUSATE SODIUM Pharmaceutical Manufacturers / Labelers: